Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia

Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia

Background: The pathophysiology of schizophrenia, a major psychiatric disorder, remains elusive. In this study, the role of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor (RXR) families, belonging to the ligand-activated nuclear receptor superfamily, in schizophrenia, was anal...

Full description

Bibliographic Details
Main Authors: Yuina Wada, Motoko Maekawa, Tetsuo Ohnishi, Shabeesh Balan, Shigeru Matsuoka, Kazuya Iwamoto, Yoshimi Iwayama, Hisako Ohba, Akiko Watanabe, Yasuko Hisano, Yayoi Nozaki, Tomoko Toyota, Tomomi Shimogori, Masanari Itokawa, Tetsuyuki Kobayashi, Takeo Yoshikawa
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:EBioMedicine
Subjects:
Molecular inversion probes (MIP)
Peroxisome proliferator-activated receptor α (PPARα)
Schizophrenia
Synaptogenesis
Therapeutic drug
Phencyclidine (PCP)
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396420305065

Internet

http://www.sciencedirect.com/science/article/pii/S2352396420305065

Similar Items